Literature DB >> 19273254

The host immunologic response to West Nile encephalitis virus.

Michael S Diamond1, Erin Mehlhop, Theodore Oliphant, Melanie A Samuel.   

Abstract

West Nile encephalitis virus (WNV) is a small, enveloped, mosquito-transmitted, positive-polarity RNA virus of the Flaviviridae family. This virus is closely related to other arthropod-borne viruses that cause human disease including Dengue, Yellow fever, and Japanese encephalitis viruses. WNV cycles in nature between mosquitoes and birds, but also infects human, horses, and other vertebrates. In humans, WNV disseminates to the central nervous system (CNS) and causes severe disease primarily in the immunocompromised and elderly. Experimental studies have made significant progress in dissecting the viral and host factors that determine the pathogenesis and outcome of WNV infection. This review will focus on the interactions between WNV and the protective and pathogenic host immune responses.

Entities:  

Mesh:

Year:  2009        PMID: 19273254     DOI: 10.2741/3432

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  29 in total

1.  Immune-mediated loss of transgene expression from virally transduced brain cells is irreversible, mediated by IFNγ, perforin, and TNFα, and due to the elimination of transduced cells.

Authors:  Jeffrey M Zirger; Mariana Puntel; Josee Bergeron; Mia Wibowo; Rameen Moridzadeh; Niyati Bondale; Carlos Barcia; Kurt M Kroeger; Chunyan Liu; Maria G Castro; Pedro R Lowenstein
Journal:  Mol Ther       Date:  2012-01-10       Impact factor: 11.454

2.  NIAID workshop on Flavivirus immunity.

Authors:  Alison D Augustine; M Cristina Cassetti; Francis A Ennis; Eva Harris; William H Hildebrand; Patricia M Repik
Journal:  Viral Immunol       Date:  2010-06       Impact factor: 2.257

Review 3.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

4.  Integrated analysis of microRNAs and their disease related targets in the brain of mice infected with West Nile virus.

Authors:  Mukesh Kumar; Vivek R Nerurkar
Journal:  Virology       Date:  2014-01-31       Impact factor: 3.616

5.  Regulatory T cells shape the resident memory T cell response to virus infection in the tissues.

Authors:  Jessica B Graham; Andreia Da Costa; Jennifer M Lund
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

6.  Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants.

Authors:  Qiang Chen; Junyun He; Waranyoo Phoolcharoen; Hugh S Mason
Journal:  Hum Vaccin       Date:  2011-03-01

Review 7.  Innate immune control of West Nile virus infection.

Authors:  Alvaro Arjona; Penghua Wang; Ruth R Montgomery; Erol Fikrig
Journal:  Cell Microbiol       Date:  2011-09-22       Impact factor: 3.715

8.  Classification of dengue fever patients based on gene expression data using support vector machines.

Authors:  Ana Lisa V Gomes; Lawrence J K Wee; Asif M Khan; Laura H V G Gil; Ernesto T A Marques; Carlos E Calzavara-Silva; Tin Wee Tan
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

9.  Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death.

Authors:  Mukesh Kumar; Saguna Verma; Vivek R Nerurkar
Journal:  J Neuroinflammation       Date:  2010-10-31       Impact factor: 8.322

10.  CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons.

Authors:  Bimmi Shrestha; Amelia K Pinto; Sharone Green; Irene Bosch; Michael S Diamond
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.